Financials · ESTA

Establishment Labs Holdings Inc. (ESTA) financials

For the twelve months ended Sep 30, 2026, Establishment Labs Holdings Inc. reported $264.03M of revenue and -$38.45M of net income.

Revenue, TTM
$264.03M
Revenue growth, YoY
+38.3%
Net income, TTM
-$38.45M
Net margin
-14.6%
Free cash flow, TTM
-$21.60M
EPS, diluted, TTM
-$1.26
Cash
$75.81M
Total debt
$267.82M
P/S
7.56
Market cap
$2.00B
Annual revenue$211.08M
FY2017FY2025
Annual net income-$51.06M
FY2017FY2025
Annual free cash flow-$56.94M
FY2017FY2025

ESTA revenue and earnings growth

ESTA revenueQ3 2026$71.99M

Quarter YoY
+33.9%
QoQ
+6.6%
FY YoY
+27.1%
5Y CAGR
+20.0%

ESTA revenue was $71.99M in fiscal Q3 2026 (ended Sep 30, 2026), up 33.9% from a year earlier and up 6.6% from the prior quarter. For the full fiscal 2025 it was $211.08M, up 27.1% from fiscal 2024. Compound annual growth was +20.0% over 5 years. It rose in 7 of the last 8 fiscal years. Fiscal 2025 is the highest of the 9 fiscal years on file.

ESTA net incomeQ3 2026-$10.71M

ESTA net income was -$10.71M in fiscal Q3 2026 (ended Sep 30, 2026), compared with -$11.15M a year earlier. For the full fiscal 2025 it was -$51.06M, compared with -$84.60M in fiscal 2024.

ESTA EPSQ3 2026-$0.35

ESTA diluted EPS was -$0.35 in fiscal Q3 2026 (ended Sep 30, 2026), compared with -$0.38 a year earlier. For the full fiscal 2025 it was -$1.72, compared with -$3.00 in fiscal 2024.

ESTA free cash flowQ3 2026$6.81M

ESTA free cash flow was $6.81M in fiscal Q3 2026 (ended Sep 30, 2026), compared with -$13.10M a year earlier. For the full fiscal 2025 it was -$56.94M, compared with -$64.63M in fiscal 2024.

Export CSV

Income statement

Income statement
Line item
Dec 31, 2025
Dec 31, 2024
Dec 31, 2023
Dec 31, 2022
Dec 31, 2021
Dec 31, 2020
Dec 31, 2019
Dec 31, 2018
Dec 31, 2017
Revenue$211.08M$166.03M$165.15M$161.70M$126.68M$84.68M$89.56M$61.21M$34.68M
Cost of revenue$64.77M$56.50M$58.17M$55.10M$41.28M$32.17M$34.70M$25.09M$16.98M
Gross profit$146.31M$109.53M$106.98M$106.59M$85.40M$52.50M$54.86M$36.12M$17.70M
Research and development$20.25M$19.71M$26.43M$20.27M$18.32M$13.79M$14.99M$12.69M$6.86M
Selling, general and admin$165.07M$139.81M$145.57M$125.98M$92.23M$66.63M$70.81M$47.30M$30.82M
Operating income-$39.01M-$49.99M-$65.03M-$39.66M-$25.14M-$27.92M-$30.94M-$23.86M-$19.98M
Interest expense$25.26M$20.83M$15.39M$11.76M$9.06M$9.37M$8.70M$8.81M$10.42M
Pre-tax income-$58.02M-$84.63M-$78.58M-$72.82M-$39.71M-$38.02M-$37.51M-$20.88M-$34.79M
Income tax-$6.96M-$32.0K-$81.0K$2.38M$1.43M$104.0K$640.0K$215.0K$105.0K
Net income-$51.06M-$84.60M-$78.50M-$75.21M-$41.14M-$38.12M-$38.15M-$21.10M-$34.90M
EPS, basic-$1.72-$3.00-$3.07-$3.08-$1.72-$1.63-$1.86-$1.22-$3.41
EPS, diluted-$1.72-$3.00-$3.07-$3.08-$1.72-$1.63-$1.86-$1.22-$3.41
Diluted shares29.6M28.2M25.6M24.5M24.0M23.3M20.5M17.4M10.2M

Balance sheet

Balance sheet
Line item
Dec 31, 2025
Dec 31, 2024
Dec 31, 2023
Dec 31, 2022
Dec 31, 2021
Dec 31, 2020
Dec 31, 2019
Dec 31, 2018
Dec 31, 2017
Cash and equivalents$75.57M$90.35M$40.03M$66.36M$53.41M$84.52M$37.66M$52.64M$10.86M
Receivables$77.50M$65.00M$46.92M$35.42M$24.44M$19.13M$22.77M$17.65M$13.11M
Inventory$85.61M$78.77M$79.47M$36.58M$28.41M$23.21M$28.66M$24.84M$13.17M
Current assets$249.94M$243.04M$174.90M$149.90M$113.27M$132.30M$95.84M$99.44M$39.38M
Goodwill$1.21M$1.21M$465.0K$465.0K$465.0K$465.0K$465.0K$465.0K$465.0K
Total assets$357.17M$346.83M$268.64M$211.06M$139.53M$156.39M$116.53M$116.57M$57.09M
Current liabilities$82.14M$68.28M$57.15M$38.96M$31.89M$25.90M$23.24M$16.45M$57.44M
Short-term debt-$0-------
Long-term debt$247.52M$219.58M$188.74M$175.46M$51.91M$49.83M$48.14M--
Total debt$247.52M$219.58M$188.74M$175.46M$51.91M$49.83M$48.14M--
Total liabilities$333.62M$293.74M$250.25M$219.25M$88.79M$81.43M$76.92M$47.09M$62.11M
Shareholders' equity$23.55M$53.09M$18.39M-$8.19M$50.74M$74.96M$39.61M$69.48M-$5.01M

Cash flow

Cash flow
Line item
Dec 31, 2025
Dec 31, 2024
Dec 31, 2023
Dec 31, 2022
Dec 31, 2021
Dec 31, 2020
Dec 31, 2019
Dec 31, 2018
Dec 31, 2017
Operating cash flow-$50.89M-$58.52M-$88.51M-$52.17M-$27.53M-$12.51M-$29.98M-$33.88M-$31.97M
Capital expenditures$6.05M$6.11M$7.91M$2.85M$2.42M$2.11M$6.29M$1.73M$901.0K
Free cash flow-$56.94M-$64.63M-$96.42M-$55.02M-$29.96M-$14.62M-$36.27M-$35.62M-$32.87M
Investing cash flow-$7.03M-$15.61M-$24.55M-$34.79M-$7.16M-$5.56M-$7.77M-$5.73M-$845.0K
Financing cash flow$40.43M$125.89M$86.23M$100.25M$4.05M$64.67M$22.79M$81.53M$42.99M
Share repurchases-------$0$4.51M
Stock-based compensation$11.41M$14.40M$14.36M$13.36M$10.41M----
Depreciation and amortization$6.20M$4.70M$2.80M$2.50M$2.50M----

Key ratios

Key ratios
Line item
Dec 31, 2025
Dec 31, 2024
Dec 31, 2023
Dec 31, 2022
Dec 31, 2021
Dec 31, 2020
Dec 31, 2019
Dec 31, 2018
Dec 31, 2017
Revenue growth, YoY27.1%0.5%2.1%27.6%49.6%-5.5%46.3%76.5%-
Gross margin69.3%66.0%64.8%65.9%67.4%62.0%61.3%59.0%51.0%
Operating margin-18.5%-30.1%-39.4%-24.5%-19.8%-33.0%-34.5%-39.0%-57.6%
Net margin-24.2%-51.0%-47.5%-46.5%-32.5%-45.0%-42.6%-34.5%-100.6%
Free cash flow margin-27.0%-38.9%-58.4%-34.0%-23.6%-17.3%-40.5%-58.2%-94.8%
Return on equity-216.9%-159.3%-426.8%--81.1%-50.9%-96.3%-30.4%-
Return on assets-14.3%-24.4%-29.2%-35.6%-29.5%-24.4%-32.7%-18.1%-61.1%
Current ratio3.043.563.063.853.555.114.126.050.69
Debt to equity10.514.1410.26-1.020.661.22--

Source: XBRL data Establishment Labs Holdings Inc. files with the SEC, latest filing dated Nov 6, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.

* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.

Per-share figures are as filed. The filings show no stock split in these periods.

EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.

ESTA peers

CompanyRevenueGrowthNet incomeNet marginMarket cap
ESTA$264.03M+38.3%-$38.45M-14.6%$2.00B
ISRG$11.58B+20.5%$2.96B25.5%$156.96B
EW$6.67B+13.4%$1.02B15.3%$58.73B
STE$6.17B+8.1%$826.90M13.4%$24.60B
ZBH$8.57B+7.0%$767.30M9.0%$19.98B
MAS$7.67B+0.9%$926.00M12.1%$15.85B
SNN$6.16B+6.1%$625.00M10.1%$13.04B
ALGN$4.16B+4.4%$491.87M11.8%$11.70B
AIT$5.06B+8.5%$424.12M8.4%$10.35B

ESTA FAQ

9 questions
  • What is ESTA revenue?
    Establishment Labs Holdings Inc. (ESTA) reported $264.03M of revenue for the twelve months ended Sep 30, 2026. That is up 38.3% from the year before. Revenue for fiscal 2025 was $211.08M.
  • Is ESTA profitable?
    No. Establishment Labs Holdings Inc. reported a net loss of $38.45M for the twelve months ended Sep 30, 2026.
  • How much cash and debt does ESTA have?
    Establishment Labs Holdings Inc. reported $75.81M in cash and cash equivalents and $267.82M of debt on its most recent balance sheet in SEC filings.
  • How fast is ESTA revenue growing?
    Establishment Labs Holdings Inc.'s revenue changed +27.1% in fiscal 2025, to $211.08M. Its compound annual growth rate was +20.0% over 5 years.
  • What is ESTA gross margin?
    Establishment Labs Holdings Inc.'s gross profit was $185.29M on $264.03M of revenue for the twelve months ended Sep 30, 2026, a gross margin of 70.2%.
  • What is ESTA free cash flow?
    Establishment Labs Holdings Inc. generated -$21.60M of free cash flow for the twelve months ended Sep 30, 2026, which is operating cash flow of -$13.38M less capital expenditures.
  • What is ESTA earnings per share?
    Diluted earnings per share were -$1.26 for the twelve months ended Sep 30, 2026, from SEC filings, restated for any stock split those filings show.
  • When did ESTA last report financial results?
    The latest statements here come from Establishment Labs Holdings Inc.'s 10-Q filed on Nov 6, 2026, covering the period ended Sep 30, 2026.
  • Where does this ESTA financial data come from?
    Quantisnow builds these statements from the structured XBRL data Establishment Labs Holdings Inc. files with the SEC. It is provided for information only and is not investment advice.